Beyond Metabolic Health: The Emerging Frontier of Incretin Therapies in Addiction

from TheBrief.Health · host TheBrief.Health

Emerging evidence suggests GLP-1 receptor agonists may reduce alcohol cravings and heavy drinking, offering a promising new treatment approach for alcohol use disorder, especially with obesity.

Episode metadata supplied by the publisher feed · Published Jul 9, 2026

Embed this episode

Attribution link and audio player

NOW PLAYING

Beyond Metabolic Health: The Emerging Frontier of Incretin Therapies in Addiction

0:00 1:56

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of TheBrief.Health?

This episode is 1 minute long.

When was this TheBrief.Health episode published?

This episode was published on July 9, 2026.

Can I download this TheBrief.Health episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!